Aspire Biopharma Holdings, Inc. (ASBP)
9.00
+0.39
(+4.53%)
USD |
NASDAQ |
Sep 10, 14:41
Aspire Biopharma Holdings Profit Margin (Quarterly) : -2.01K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.01K% |
| March 31, 2026 | -11.35K% |
| Date | Value |
|---|---|
| December 31, 2025 | -109.5K% |
| September 30, 2025 | -97.39K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Resonate Blends, Inc. | -398.9% |
| Breakthrough Chemistry, Inc. | -43.31K% |
| Kaya Holdings, Inc. | -- |
| Cardiac Biotech Solutions, Inc. | -341.3% |
| Endexx Corp. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -217.8% |
| Return on Invested Capital | -462.8% |
| Gross Profit Margin (Quarterly) | 19.49% |
| Operating Margin (Quarterly) | -3.88K% |
| Return on Net Operating Assets | -5.83K% |